Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.60 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | CA12 | O43570 | 2/20 | 0.55 |
| ▸ | CA9 | Q16790 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.50 |
| ▸ | GBA1 | P04062 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2624207 | 0.84 | ALDH1A1 (0.63) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL5567042 | 0.83 | ALDH1A1 (0.75) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL18498695 | 0.83 | SIGMAR1 (0.55) | ALDH1A1MEN1KMT2ACA2GAA | |
| SCHEMBL6020322 | 0.83 | ALDH1A1 (0.60) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL3874983 | 0.82 | ALDH1A1 (0.61) | ALDH1A1MEN1KMT2ACA2LMNA | |
| SCHEMBL20390809 | 0.82 | ALDH1A1 (0.69) | ALDH1A1MEN1KMT2ACA2 | |
| SCHEMBL8213969 | 0.81 | ALDH1A1 (0.72) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL7094852 | 0.80 | ALDH1A1 (0.79) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL7201051 | 0.80 | ALDH1A1 (0.86) | ALDH1A1MEN1KMT2ACA12CA9 | |
| SCHEMBL20512270 | 0.79 | ALDH1A1 (0.55) | ALDH1A1MEN1KMT2ACA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4652154-A1 | NOVEL ALPK1 INHIBITORS | Pyrotech (Beijing) Biotechnology Co., Ltd. (CN) | 2025-11-26 | — | — | EP | disclosed |
| WO-2024153225-A1 | NOVEL ALPK1 INHIBITORS | PYROTECH (BEIJING) BIOTECHNOLOGY CO., LTD. (CN) | 2024-07-25 | — | — | WO | disclosed |
| US-20180354963-A1 | NOVEL LACTONES | PURDUE RESEARCH FOUNDATION (US) | 2018-12-13 | — | — | US | disclosed |
| US-10138252-B1 | Lactones | PURDUE RESEARCH FOUNDATION (US) | 2018-11-27 | — | — | US | disclosed |
| US-20180305371-A1 | NOVEL LACTONES | PURDUE RESEARCH FOUNDATION (US) | 2018-10-25 | — | — | US | disclosed |
| US-10087190-B1 | Lactones | PURDUE RESEARCH FOUNDATION (US) | 2018-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180354963-A1 | NOVEL LACTONES | DHPS, FDPS, LSS | ALDH1A1 2443/4885MEN1 849/4885KMT2A 3125/4885 |
| US-20180305371-A1 | NOVEL LACTONES | DHPS, FDPS, LSS | ALDH1A1 2443/4885MEN1 849/4885KMT2A 3125/4885 |
| US-10138252-B1 | Lactones | DHPS, FDPS, LSS | ALDH1A1 2208/4885MEN1 624/4885KMT2A 3286/4885 |
| US-10087190-B1 | Lactones | DHPS, FDPS, LSS | ALDH1A1 2208/4885MEN1 624/4885KMT2A 3286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.